The price of Beyond Air Inc. (NASDAQ:XAIR) shares last traded on Wall Street rose 0.78% to $6.49.
XAIR stock price is now 3.87% away from the 50-day moving average and -10.65% away from the 200-day moving average. The market capitalization of the company currently stands at $192.62M.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
With the price target of $12, Truist recently initiated with Buy rating for Beyond Air Inc. (NASDAQ: XAIR). On October 22, 2019, Oppenheimer recently initiated its ‘Outperform’ rating on the stock quoting a target price of $9.
In other news, Carey Robert, Director bought 20,000 shares of the company’s stock on Dec 07. The stock was bought for $115,000 at an average price of $5.75. Upon completion of the transaction, the Director now directly owns 842,323 shares in the company, valued at $5.47 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 29, Director Carey Robert bought 15,000 shares of the business’s stock. A total of $86,248 was incurred on buying the stock at an average price of $5.75. This leaves the insider owning 822,323 shares of the company worth $5.34 million. Insiders disposed of 108,100 shares of company stock worth roughly $0.7 million over the past 1 year. A total of 9.70% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in XAIR stock. A new stake in Beyond Air Inc. shares was purchased by EAM INVESTORS, LLC during the first quarter worth $2,079,000. MILLENNIUM MANAGEMENT LLC invested $1,005,000 in shares of XAIR during the first quarter. In the first quarter, EAM GLOBAL INVESTORS LLC acquired a new stake in Beyond Air Inc. valued at approximately $975,000. PARKMAN HEALTHCARE PARTNERS LLC acquired a new stake in XAIR for approximately $821,000. RESOLUTE CAPITAL ASSET PARTNERS LLC purchased a new stake in XAIR valued at around $714,000 in the second quarter. In total, there are 55 active investors with 19.20% ownership of the company’s stock.
A candlestick chart of Beyond Air Inc. (NASDAQ: XAIR) showed a price of $6.44 on Friday morning. During the past 12 months, Beyond Air Inc. has had a low of $4.78 and a high of $11.76. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 6.50, and a quick ratio of 6.40. The fifty day moving average price for XAIR is $6.25 and a two-hundred day moving average price translates $7.26 for the stock.
The latest earnings results from Beyond Air Inc. (NASDAQ: XAIR) was released for Jun, 2022. According to the Medical Devices Company, earnings per share came in at -$0.37, beating analysts’ expectations of -$0.47 by 0.1. This compares to -$0.36 EPS in the same period last year.
Beyond Air Inc.(XAIR) Company Profile
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
